questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
Oxidoreductases acting on sulfur group donors
Oxidoreductases acting on sulfur group donors : Questions médicales fréquentes
Termes MeSH sélectionnés :
Ventricular Function, Left
Diagnostic
5
Déficience enzymatique
Tests biochimiques
Spectrophotométrie
Dosage enzymatique
Tests génétiques
Mutations
Fatigue
Troubles métaboliques
Analyses sanguines
Métabolites
Symptômes
5
Sulfure d'hydrogène
Troubles neurologiques
Troubles métaboliques
Déséquilibres électrolytiques
Oxydoréductases
Symptômes
Hyperlipidémie
Anomalies hépatiques
Troubles respiratoires
Déséquilibres métaboliques
Prévention
5
Prévention
Alimentation équilibrée
Dépistage précoce
Anomalies enzymatiques
Éducation des patients
Détection rapide
Mode de vie sain
Exercice
Traitements
5
Suppléments enzymatiques
Modifications diététiques
Thérapie génique
Déficiences enzymatiques
Médicaments
Régulation des métabolites
Traitements personnalisés
Besoins individuels
Diététiciens
Régimes alimentaires
Complications
5
Complications
Troubles neurologiques
Complications réversibles
Traitement approprié
Qualité de vie
Activités quotidiennes
Prévention des complications
Suivi médical
Risques à long terme
Maladies chroniques
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Âge
Troubles métaboliques
Habitudes alimentaires
Risque de maladies
Facteurs environnementaux
Toxines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Oxidoreductases acting on sulfur group donors : Questions médicales les plus fréquentes",
"headline": "Oxidoreductases acting on sulfur group donors : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Oxidoreductases acting on sulfur group donors : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-16",
"dateModified": "2025-04-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Oxidoreductases acting on sulfur group donors"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxidoreductases",
"url": "https://questionsmedicales.fr/mesh/D010088",
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases",
"code": {
"@type": "MedicalCode",
"code": "D010088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ferredoxine-NADP reductase",
"alternateName": "Ferredoxin-NADP Reductase",
"url": "https://questionsmedicales.fr/mesh/D005287",
"about": {
"@type": "MedicalCondition",
"name": "Ferredoxine-NADP reductase",
"code": {
"@type": "MedicalCode",
"code": "D005287",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.667.076"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glutarédoxines",
"alternateName": "Glutaredoxins",
"url": "https://questionsmedicales.fr/mesh/D054477",
"about": {
"@type": "MedicalCondition",
"name": "Glutarédoxines",
"code": {
"@type": "MedicalCode",
"code": "D054477",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.667.084"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glutathione reductase",
"alternateName": "Glutathione Reductase",
"url": "https://questionsmedicales.fr/mesh/D005980",
"about": {
"@type": "MedicalCondition",
"name": "Glutathione reductase",
"code": {
"@type": "MedicalCode",
"code": "D005980",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.667.092"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hydrogensulfite reductase",
"alternateName": "Hydrogensulfite Reductase",
"url": "https://questionsmedicales.fr/mesh/D050885",
"about": {
"@type": "MedicalCondition",
"name": "Hydrogensulfite reductase",
"code": {
"@type": "MedicalCode",
"code": "D050885",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.667.124"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protein-disulfide reductase (glutathione)",
"alternateName": "Protein Disulfide Reductase (Glutathione)",
"url": "https://questionsmedicales.fr/mesh/D011490",
"about": {
"@type": "MedicalCondition",
"name": "Protein-disulfide reductase (glutathione)",
"code": {
"@type": "MedicalCode",
"code": "D011490",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.667.186"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfite dehydrogenase",
"alternateName": "Sulfite Dehydrogenase",
"url": "https://questionsmedicales.fr/mesh/D050902",
"about": {
"@type": "MedicalCondition",
"name": "Sulfite dehydrogenase",
"code": {
"@type": "MedicalCode",
"code": "D050902",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.667.217"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfite oxidase",
"alternateName": "Sulfite Oxidase",
"url": "https://questionsmedicales.fr/mesh/D050876",
"about": {
"@type": "MedicalCondition",
"name": "Sulfite oxidase",
"code": {
"@type": "MedicalCode",
"code": "D050876",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.667.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfite reductase (ferredoxin)",
"alternateName": "Sulfite Reductase (Ferredoxin)",
"url": "https://questionsmedicales.fr/mesh/D050889",
"about": {
"@type": "MedicalCondition",
"name": "Sulfite reductase (ferredoxin)",
"code": {
"@type": "MedicalCode",
"code": "D050889",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.667.374"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfite reductase (NADPH)",
"alternateName": "Sulfite Reductase (NADPH)",
"url": "https://questionsmedicales.fr/mesh/D050864",
"about": {
"@type": "MedicalCondition",
"name": "Sulfite reductase (NADPH)",
"code": {
"@type": "MedicalCode",
"code": "D050864",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.667.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thioredoxin reductase 1",
"alternateName": "Thioredoxin Reductase 1",
"url": "https://questionsmedicales.fr/mesh/D054481",
"about": {
"@type": "MedicalCondition",
"name": "Thioredoxin reductase 1",
"code": {
"@type": "MedicalCode",
"code": "D054481",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.667.750.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thioredoxin reductase 2",
"alternateName": "Thioredoxin Reductase 2",
"url": "https://questionsmedicales.fr/mesh/D054482",
"about": {
"@type": "MedicalCondition",
"name": "Thioredoxin reductase 2",
"code": {
"@type": "MedicalCode",
"code": "D054482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.667.750.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases acting on sulfur group donors",
"alternateName": "Oxidoreductases Acting on Sulfur Group Donors",
"code": {
"@type": "MedicalCode",
"code": "D050862",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Inês A C Pereira",
"url": "https://questionsmedicales.fr/author/In%C3%AAs%20A%20C%20Pereira",
"affiliation": {
"@type": "Organization",
"name": "Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal."
}
},
{
"@type": "Person",
"name": "Shi Xu",
"url": "https://questionsmedicales.fr/author/Shi%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Washington State University, Pullman, WA, 99164, USA."
}
},
{
"@type": "Person",
"name": "Ming Xian",
"url": "https://questionsmedicales.fr/author/Ming%20Xian",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Washington State University, Pullman, WA, 99164, USA."
}
},
{
"@type": "Person",
"name": "Wei Li",
"url": "https://questionsmedicales.fr/author/Wei%20Li",
"affiliation": {
"@type": "Organization",
"name": "School of Environmental Science and Engineering, Suzhou University of Science and Technology, Suzhou 215009, China; National and Local Joint Engineering Laboratory for Municipal Sewage Resource Utilization Technology, Suzhou University of Science and Technology, Suzhou 215009, China."
}
},
{
"@type": "Person",
"name": "Dorry L Segev",
"url": "https://questionsmedicales.fr/author/Dorry%20L%20Segev",
"affiliation": {
"@type": "Organization",
"name": "Department of Surgery, New York University Grossman School of Medicine, New York, NY."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Supra-Normal Left Ventricular Function.",
"datePublished": "2023-09-19",
"url": "https://questionsmedicales.fr/article/37734305",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amjcard.2023.08.169"
}
},
{
"@type": "ScholarlyArticle",
"name": "Insight of electrocardiographic and electrophysiological parameters on the left ventricular function in patients with ventricular arrhythmia from left ventricular summit.",
"datePublished": "2023-04-16",
"url": "https://questionsmedicales.fr/article/37061887",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jce.15904"
}
},
{
"@type": "ScholarlyArticle",
"name": "The relationship between ascending aortic diameter with left atrial functions and left ventricular mass index in a population with normal left ventricular systolic function.",
"datePublished": "2023-06-12",
"url": "https://questionsmedicales.fr/article/37306963",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/echo.15635"
}
},
{
"@type": "ScholarlyArticle",
"name": "Left ventricular function and volumes from gated [",
"datePublished": "2022-07-11",
"url": "https://questionsmedicales.fr/article/35819716",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12350-022-03029-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Relationship between left ventricular mechanical synchrony and left ventricular systolic function: a CZT-SPECT analysis.",
"datePublished": "2022-09-22",
"url": "https://questionsmedicales.fr/article/36138379",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12872-022-02863-8"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "Oxidoreductases acting on sulfur group donors",
"item": "https://questionsmedicales.fr/mesh/D050862"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Oxidoreductases acting on sulfur group donors - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Oxidoreductases acting on sulfur group donors",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Oxidoreductases acting on sulfur group donors",
"description": "Comment diagnostiquer une déficience en oxydoréductases ?\nQuels tests sont utilisés pour évaluer l'activité des oxydoréductases ?\nLes tests génétiques sont-ils utiles pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème enzymatique ?\nComment les analyses sanguines aident-elles au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Ventricular+Function,+Left#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Oxidoreductases acting on sulfur group donors",
"description": "Quels sont les symptômes d'une déficience en sulfure d'hydrogène ?\nComment se manifestent les troubles métaboliques liés aux oxydoréductases ?\nLes symptômes varient-ils selon le type d'oxydoréductase ?\nQuels signes cliniques sont associés aux maladies métaboliques ?\nLes troubles respiratoires peuvent-ils être liés aux oxydoréductases ?",
"url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Ventricular+Function,+Left#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Oxidoreductases acting on sulfur group donors",
"description": "Comment prévenir les maladies liées aux oxydoréductases ?\nLes dépistages précoces sont-ils recommandés ?\nL'éducation des patients est-elle importante ?\nLes vaccinations peuvent-elles jouer un rôle préventif ?\nComment le mode de vie influence-t-il la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Ventricular+Function,+Left#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Oxidoreductases acting on sulfur group donors",
"description": "Quels traitements sont disponibles pour les déficiences enzymatiques ?\nLa thérapie génique est-elle une option pour ces maladies ?\nComment les médicaments peuvent-ils aider ?\nLes traitements sont-ils personnalisés selon le patient ?\nQuels rôles jouent les diététiciens dans le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Ventricular+Function,+Left#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Oxidoreductases acting on sulfur group donors",
"description": "Quelles complications peuvent survenir avec ces déficiences ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles être prévenues ?\nQuels sont les risques de complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Ventricular+Function,+Left#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Oxidoreductases acting on sulfur group donors",
"description": "Quels sont les facteurs de risque pour les maladies métaboliques ?\nL'âge est-il un facteur de risque ?\nLe stress peut-il influencer ces maladies ?\nLes habitudes alimentaires jouent-elles un rôle ?\nLes facteurs environnementaux sont-ils significatifs ?",
"url": "https://questionsmedicales.fr/mesh/D050862?mesh_terms=Ventricular+Function,+Left#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en oxydoréductases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses biochimiques sont utilisés pour diagnostiquer."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des oxydoréductases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de spectrophotométrie et des dosages enzymatiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations affectant les oxydoréductases."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème enzymatique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, des douleurs musculaires ou des troubles métaboliques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les analyses sanguines aident-elles au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les analyses sanguines mesurent les niveaux de métabolites et d'enzymes spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en sulfure d'hydrogène ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles neurologiques, des douleurs abdominales et des nausées."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les troubles métaboliques liés aux oxydoréductases ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent se manifester par des déséquilibres électrolytiques et des anomalies de croissance."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'oxydoréductase ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'enzyme spécifique impliquée."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés aux maladies métaboliques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'hyperlipidémie, l'hyperglycémie et des anomalies hépatiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires peuvent-ils être liés aux oxydoréductases ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles respiratoires peuvent être causés par des déséquilibres métaboliques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux oxydoréductases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et des bilans de santé réguliers peuvent aider à prévenir ces maladies."
}
},
{
"@type": "Question",
"name": "Les dépistages précoces sont-ils recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages précoces peuvent identifier des anomalies enzymatiques avant l'apparition des symptômes."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les signes et symptômes peut aider à une détection rapide."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles jouer un rôle préventif ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant exercice et nutrition, peut réduire le risque de maladies métaboliques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les déficiences enzymatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des suppléments enzymatiques et des modifications diététiques."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour ces maladies ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique est explorée comme une option pour corriger des déficiences spécifiques."
}
},
{
"@type": "Question",
"name": "Comment les médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent aider à réguler les niveaux de métabolites et à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés selon le patient ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction des besoins individuels du patient."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent les diététiciens dans le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les diététiciens aident à concevoir des régimes alimentaires adaptés aux besoins métaboliques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ces déficiences ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des troubles neurologiques, des maladies cardiovasculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent réduire la qualité de vie en limitant les activités quotidiennes et en causant de la douleur."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être prévenues ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une gestion proactive des symptômes et un suivi médical régulier peuvent aider."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des maladies chroniques et des défaillances organiques si non traitées."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les maladies métaboliques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, une mauvaise alimentation et le manque d'exercice."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé peut augmenter le risque de développer des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer ces maladies ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut aggraver les symptômes et augmenter le risque de complications."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires jouent-elles un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses et en sucres peut augmenter le risque de maladies."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux sont-ils significatifs ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut affecter l'activité des oxydoréductases."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 10/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Publications dans "Oxidoreductases acting on sulfur group donors" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Washington State University, Pullman, WA, 99164, USA.
Publications dans "Oxidoreductases acting on sulfur group donors" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Washington State University, Pullman, WA, 99164, USA.
School of Pharmaceutics Science, Guangzhou Medical University, Guangzhou, Guangdong, 511436, P. R. China.
Publications dans "Oxidoreductases acting on sulfur group donors" :
2 publications dans cette catégorie
Affiliations :
School of Environmental Science and Engineering, Suzhou University of Science and Technology, Suzhou 215009, China; National and Local Joint Engineering Laboratory for Municipal Sewage Resource Utilization Technology, Suzhou University of Science and Technology, Suzhou 215009, China.
Publications dans "Oxidoreductases acting on sulfur group donors" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, New York University Grossman School of Medicine, New York, NY.
Publications dans "Oxidoreductases acting on sulfur group donors" :
2 publications dans cette catégorie
Affiliations :
University of Florence, NEUROFARBA Dept., Sezione di Scienze Farmaceutiche, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Florence, Italy. Electronic address: claudiu.supuran@unfi.it.
Publications dans "Oxidoreductases acting on sulfur group donors" :
2 publications dans cette catégorie
Affiliations :
Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Institute of Urology, Capital Medical University, Beijing, China.
Publications dans "Oxidoreductases acting on sulfur group donors" :
2 publications dans cette catégorie
Affiliations :
College of Food Science and Engineering, Northwest A&F University, Yangling, China.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Institut für Mikrobiologie & Biotechnologie, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Institut für Mikrobiologie & Biotechnologie, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Institut für Mikrobiologie & Biotechnologie, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA, USA.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA, USA.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA, USA.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, Stanford University, Stanford, CA, USA.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA, USA.
Department of Chemistry, University of California, Berkeley, Berkeley, CA, USA.
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA, USA.
Publications dans "Oxidoreductases acting on sulfur group donors" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of California, Berkeley, Berkeley, CA, USA.
Publications dans "Oxidoreductases acting on sulfur group donors" :
Heart failure (HF) is often categorized by left ventricular (LV) ejection fraction (LVEF). A new category of HF characterized by supra-normal LVEF (>65%), named HF with supra-normal ejection fraction ...
Ventricular arrhythmia (VA) commonly originate from the left ventricular summit (LVS) and results in left ventricular (LV) dysfunction in some patients; however, factors related to LV cardiomyopathy h...
Between 2013 and 2018, a total of 139 patients (60.7% men; mean age 53.2 ± 13.9 years old) underwent catheter ablation for LVS VA in two centers. Detailed patient demographics, electrocardiograms, ele...
Acute procedural success was achieved in 92.8% of patients. There were 40 patients (28.8%) with LV cardiomyopathy, and the mean LVEF improved from 37.5 ± 9.3% to 48.5 ± 10.2% after ablation (p < .001)...
In patients with VA from the LVS, PVC QRSd and AEAD are factors associated with deteriorating LV systolic function. Catheter ablation can reverse LV remodeling. Narrower QRSd and better LVEF are assoc...
Ascending aortic dilatation is a common clinical issue. In the present study, we aimed to evaluate the relationship between ascending aortic diameter with left ventricular (LV) and left atrial (LA) fu...
A total of 127 healthy participants with normal LV systolic function took part in the study. Echocardiographic measurements were obtained from each subject....
The mean age of the participants was 43 ± 14.1 years and 76 (59.8%) were female. The mean aortic diameter of the participants was 32.2 ± 4.7 mm. A negative correlation was found between aortic diamete...
A strong correlation between ascending aortic diameter with LV and LA functions, and LVMI in individuals with normal LV systolic function....
Positron emission tomography (PET) myocardial perfusion imaging (MPI) can be used to evaluate left ventricular (LV) volumes and function. We performed a head-to-head comparison of LV function and volu...
In this prospective study, 51 patients underwent [...
LVEF and LV wall motion can be accurately assessed using [...
CZT-SPECT has good agreement in the evaluation of mechanical synchronization compared with conventional SPECT. The aim of this study was to evaluate the correlation between left ventricular mechanical...
This retrospective study involved 371 patients (239 males and 132 females, mean age 61.06 ± 11.78 years old) who underwent GMPI at the Nuclear Medicine Department of Shanxi Cardiovascular Hospital fro...
PP, PSD, PHB, HS and HK were significantly different among the four groups (F = 5.20, 188.72, 202.88, 171.05, 101.36, P < 0.001). Pairwise comparison tests showed significant differences in PSD and PH...
CZT SPECT GMPI provided left ventricular mechanical contraction synchrony parameters that correlated well with left ventricular systolic function. Worse left ventricular mechanical contraction synchro...
Left ventricle myocardium has a complex micro-architecture, which was revealed to consist of myocyte bundles arranged in a series of laminar sheetlets. Recent imaging studies demonstrated that these s...
The perioperative quantification of left and right ventricular function is cornerstone to provide optimal patient care. Echocardiography has emerged as the most important cardiac imaging modality in t...
Myocardial contractility is poorly defined and difficult to compare between studies. Contractance or myocardial active strain energy density (MASED) measures the mechanical work done per unit volume (...
Data obtained from three previously published experimental studies using trabecular tissue was used to provide contemporaneous nominal stress and strain data in 18 different scenarios with different l...
We showed that calculating MASED was feasible and provided a measure of energy production (work done) per unit volume of myocardium during contraction. The new term for contractile function, contracta...
The right ventricle (RV) in hypertrophic cardiomyopathy (HCM) tends to be neglected, as previous efforts have predominantly focused on examining the prognostic value of left ventricular (LV) abnormali...
Two hundred and ninety HCM patients with preserved LV ejection fraction (LVEF ≥ 55%) and 30 age- and sex-matched controls underwent cardiovascular magnetic resonance (CMR). All patients were followed ...
When compared to controls, HCM patients exhibited lower RV and LV peak global longitudinal systolic strains on feature-tracking analysis of cine images, while RVEF and LVEF were within the normal rang...
In HCM, RV function, including RV strain, and LV strain decrease over time despite preserved LVEF. Reduction in RV but not LV function is associated with adverse cardiovascular outcomes. Assessing RV ...
Atrial fibrillation (AF) is the most common sustained arrhythmia in humans. The onset of the arrhythmia can significantly impair cardiac function. This hemodynamic deterioration has been explained by ...
Twelve patients undergoing catheter ablation for paroxysmal AF were paced simultaneously from the proximal coronary sinus and the His bundle region according to prescribed sequences of irregular R-R i...
Simulated AF led to significant impairment of left ventricular systolic and diastolic function. Both loss of atrial contraction and heart rate irregularity significantly contributed to hemodynamic imp...
Our findings strengthen the rationale for therapeutic strategies aiming at rhythm control and heart rate regularization in patients with AF....